Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Warts 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 1Tuberculin 1PRA1 protein, Candida albicans 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Warts × PRA1 protein, Candida albicans × Clear all
NCT04399577 2020-05-27

Complement Component 3c and Tumor Necrosis Factor-α in Patients With Human Papillomavirus-Induced Cutaneous Warts

Zagazig University

Phase 2 Completed
39 enrolled

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡